These results are consistent with other reports, according to which increased expression of the gene encoding Bcl-2 in gliomas cells leads to an increase in drug resistance and a decrease in the apoptotic response in vitro (Garcia-Aranda et al. 2018). Here, BCL2 is linked to central nervous system cancer.